首页> 外国专利> CXCR3 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF INFLAMMATORY IMMUNE CELLS, IN PARTICULAR CD8+ MEMORY T CELLS

CXCR3 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF INFLAMMATORY IMMUNE CELLS, IN PARTICULAR CD8+ MEMORY T CELLS

机译:CXCR3作为识别特定CD8 +记忆T细胞中炎症性免疫细胞的表象标记

摘要

The present invention relates to a method, in particular an in vitro method, for specifically identifying the C-X-C motif chemokine receptor 3 (CXCR3) subpopulation of immune cells in a sample from a mammal comprising immune cells, in particular at least one of CD8+ effector and memory T cells, T helper (Th)1 cells and natural killer T (NKT) cells, comprising analyzing epigenetic modifications/properties of (including the methylation status) of at least one CpG position in the mammalian gene region for CXCR3 according to SEQ ID No. 1, wherein a demethylation or lack of methylation of said of at least one CpG position in said gene region is indicative for said CXCR3 specific subpopulation of immune cells in said sample, when compared to other immune cells, in particular for at least one of CD8+effector and memory T cells, T helper (Th)1 cells and natural killer T (NKT) cells. The analyses according to the invention can identify the above cells on an epigenetic level and distinguish them from all other cells in complex samples, such as, for example, other blood or immune cells. The present invention furthermore provides an improved method for quantifying the above cells, in particular in complex samples. The method can be performed without a step of purifying and/or enriching cells, preferably in whole blood and/or non-trypsinized tissue.
机译:本发明涉及一种方法,特别是体外方法,用于特异性地鉴定来自哺乳动物的样品中免疫细胞的CXC基序趋化因子受体3(CXCR3)亚群,所述样品包含免疫细胞,特别是CD8 +效应子和记忆T细胞,T辅助(Th)1细胞和自然杀伤性T(NKT)细胞,包括根据SEQ ID分析CXCR3在哺乳动物基因区域中至少一个CpG位置的表观遗传修饰/特性(包括甲基化状态) 1),其中与其他免疫细胞相比,特别是对于至少一个免疫细胞,所述基因区域中至少一个CpG位置的所述去甲基化或缺乏甲基化指示所述样品中免疫细胞的所述CXCR3特异性亚群CD8 +效应子和记忆性T细胞,T辅助(Th)1细胞和自然杀伤性T(NKT)细胞。根据本发明的分析可以在表观遗传水平上鉴定上述细胞,并将它们与复杂样品中的所有其他细胞区分开,例如其他血液或免疫细胞。本发明还提供了一种定量上述细胞的改进方法,特别是在复杂样品中。该方法可以在没有纯化和/或富集细胞的步骤中进行,优选在全血和/或非胰蛋白酶化的组织中。

著录项

  • 公开/公告号WO2019224014A1

    专利类型

  • 公开/公告日2019-11-28

    原文格式PDF

  • 申请/专利权人 EPIONTIS GMBH;

    申请/专利号WO2019EP61998

  • 发明设计人 OLEK SVEN;HELD JOSEPHIN;

    申请日2019-05-10

  • 分类号C12Q1/6883;

  • 国家 WO

  • 入库时间 2022-08-21 11:14:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号